tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Foghorn Therapeutics (FHTX)
NASDAQ:FHTX
US Market
FHTX
Foghorn Therapeutics
RESEARCH TOOLSreports

Foghorn Therapeutics (FHTX) Stock News & Sentiment

Compare
449 Followers
Maintaining Buy on Foghorn: Advancing FHD-909, Productive Discovery Engine, and Cash Runway Drive Attractive Risk–Reward Ahead of Key 2026 Catalyst
Premium
Ratings
Maintaining Buy on Foghorn: Advancing FHD-909, Productive Discovery Engine, and Cash Runway Drive Attractive Risk–Reward Ahead of Key 2026 Catalyst
8d ago
FHTX
Buy Rating on Foghorn Therapeutics Driven by Lilly Partnership Catalyst, Advancing Degrader Pipeline, and Strengthened Cash Runway
Premium
Ratings
Buy Rating on Foghorn Therapeutics Driven by Lilly Partnership Catalyst, Advancing Degrader Pipeline, and Strengthened Cash Runway
9d ago
FHTX
Foghorn Advances FHD-909 Trial and Strengthens Financial Position
Premium
Company Announcements
Foghorn Advances FHD-909 Trial and Strengthens Financial Position
9d ago
8K
FHTX
Reigniting FHD-286: Chromatin-Targeted Synergy in Menin-Resistant AML Underpins Buy Rating on Foghorn
Premium
Ratings
Reigniting FHD-286: Chromatin-Targeted Synergy in Menin-Resistant AML Underpins Buy Rating on Foghorn
11d ago
FHTX
Is FHTX a Buy, Before Earnings?
Premium
Pre-Earnings
Is FHTX a Buy, Before Earnings?
18d ago
FHTX
Foghorn Therapeutics Names Veteran Executive as New CFO
Premium
Company Announcements
Foghorn Therapeutics Names Veteran Executive as New CFO
25d ago
8K
FHTX
Jefferies Initiates Buy on Foghorn Therapeutics Driven by FHD‑909 Mid‑2026 Catalyst and Upside from Emerging EP300/CBP Degrader Pipeline
Premium
Ratings
Jefferies Initiates Buy on Foghorn Therapeutics Driven by FHD‑909 Mid‑2026 Catalyst and Upside from Emerging EP300/CBP Degrader Pipeline
1M ago
FHTX
More FHTX News >

FHTX News on the Web

Wedbush Reaffirms Their Buy Rating on Foghorn Therapeutics (FHTX)
TipRanks News
Bullish
Foghorn Therapeutics (FHTX) Receives a Buy from Guggenheim
TipRanks News
Bullish
Maintaining Buy on Foghorn: Advancing FHD-909, Productive Discovery Engine, and Cash Runway Drive Attractive Risk–Reward Ahead of Key 2026 Catalyst
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Tenax Therapeutics (TENX), RegenXBio (RGNX) and Foghorn Therapeutics (FHTX)
TipRanks News
Neutral
Buy Rating on Foghorn Therapeutics Driven by Lilly Partnership Catalyst, Advancing Degrader Pipeline, and Strengthened Cash Runway
TipRanks News
Bullish
Foghorn Advances FHD-909 Trial and Strengthens Financial Position
TipRanks News
Neutral
Foghorn Therapeutics Inc. (FHTX) Reports Q4 Loss, Beats Revenue Estimates
Zacks
Bearish
Reigniting FHD-286: Chromatin-Targeted Synergy in Menin-Resistant AML Underpins Buy Rating on Foghorn
TipRanks News
Bullish

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is FHTX’s Media Buzz Sentiment?
Currently, no data Available
What is FHTX’s weekly average amount of articles?
Currently, no data Available
What is FHTX’s News Sentiment?
Currently, no data Available
Healthcare Stocks that are Trending in the News
ABOSAcumen Pharmaceuticals
KHTRFKnight Therapeutics
IMMPImmutep
KMTSKestra Medical Technologies Ltd.
CATXPerspective Therapeutics
Showing the stocks with the most bullish news sentiment over the past week